Aggressive progression in gastric/GEJ adenocarcinoma: linitis plastica (signet-ring diffu...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-GASTRIC-TRANSFORMATION-PROGRESSION |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-26 | pending_clinical_signoff |
| Diseases | DIS-GASTRIC |
| Sources | SRC-ESMO-GASTRIC-2024 SRC-NCCN-GASTRIC-2025 |
Red Flag Origin
| Definition | Aggressive progression in gastric/GEJ adenocarcinoma: linitis plastica (signet-ring diffuse type with rigid stomach wall — historically poor prognosis), peritoneal carcinomatosis with malignant ascites, OR rapid progression on first cycle (clinical decline ≤4 weeks). Triggers MDT / early palliative-care / regimen-modification discussion. |
|---|---|
| Clinical direction | investigate |
| Category | transformation-progression |
Trigger Logic
{
"any_of": [
{
"finding": "linitis_plastica_pattern",
"value": true
},
{
"finding": "peritoneal_carcinomatosis_with_ascites",
"value": true
},
{
"finding": "rapid_decline_first_cycle",
"value": true
}
],
"type": "composite_score"
}
Notes
Linitis plastica + signet-ring biology — historically not benefited from anti-HER2 (FAST trial subgroup); CLDN18.2+ subset ~50% of diffuse-type gastric — emerging zolbetuximab benefit.
Used By
No reverse references found in the YAML corpus.